119th Congress
S. 5059
A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.
- Introduced
- In committee
- Passed Senate
- Passed House
- To President
- Became law
- Sponsor
- Ashley Moody(R-FL)
- Introduced
- Jul 21, 2026
- Policy area
- Health
- Committees
- Senate Committee on Health, Education, Labor, and Pensions
- Official text
- Introduced in Senate · Congress.gov page
Cosponsors (3)
Original cosponsors (3)
- Angela D. Alsobrooks (D-MD)
- Lisa Blunt Rochester (D-DE)
- Rick Scott (R-FL)
Summary
No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.
Latest action(Jul 21, 2026): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Roll-call votes
No recorded votes on this bill.
Actions
- Jul 21, 2026 · Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. - Jul 21, 2026
Introduced in Senate